The immunomodulatory glycan LNFPIII initiates alternative activation of murine macrophages in vivo.
about
Alternatively activated macrophages in types 1 and 2 diabetesChitohexaose activates macrophages by alternate pathway through TLR4 and blocks endotoxemiaPolarization of host immune responses by helminth-expressed glycansA Neoglycoconjugate Containing the Human Milk Sugar LNFPIII Drives Anti-Inflammatory Activation of Antigen Presenting Cells in a CD14 Dependent PathwayIL-4Ralpha-independent expression of mannose receptor and Ym1 by macrophages depends on their IL-10 responsiveness.Extracts of the rat tapeworm, Hymenolepis diminuta, suppress macrophage activation in vitro and alleviate chemically induced colitis in miceTargeted glycoproteomic analysis reveals that kappa-5 is a major, uniquely glycosylated component of Schistosoma mansoni egg antigens.STAT6⁻/⁻ mice exhibit decreased cells with alternatively activated macrophage phenotypes and enhanced disease severity in murine neurocysticercosis.Increased disease severity of parasite-infected TLR2-/- mice is correlated with decreased central nervous system inflammation and reduced numbers of cells with alternatively activated macrophage phenotypes in a murine model of neurocysticercosis.Immune modulation by Lacto-N-fucopentaose III in experimental autoimmune encephalomyelitis.Schistosome Vaccine Adjuvants in Preclinical and Clinical Research.Fasciola hepatica Surface Coat Glycoproteins Contain Mannosylated and Phosphorylated N-glycans and Exhibit Immune Modulatory Properties Independent of the Mannose ReceptorImmunomodulatory glycan LNFPIII alleviates hepatosteatosis and insulin resistance through direct and indirect control of metabolic pathwaysNovel O-linked methylated glycan antigens decorate secreted immunodominant glycoproteins from the intestinal nematode Heligmosomoides polygyrus.M2-polarized macrophages contribute to neovasculogenesis, leading to relapse of oral cancer following radiation.Heterogeneity of microglial activation in the innate immune response in the brain.Characterization of Schistosoma japonicum CP1412 protein as a novel member of the ribonuclease T2 molecule family with immune regulatory function.Mesocestoides corti intracranial infection as a murine model for neurocysticercosis.Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages.Parasitic helminths: new weapons against immunological disorders.Immunomodulatory glycan lacto-N-fucopentaose III requires clathrin-mediated endocytosis to induce alternative activation of antigen-presenting cells.Myeloid-derived suppressor cells in transplantation and cancerEvolutionary roots of arginase expression and regulation.Aberrant immune response with consequent vascular and connective tissue remodeling - causal to scleroderma and associated syndromes such as Raynaud phenomenon and other fibrosing syndromes?Immunoregulation by Taenia crassiceps and its antigens.The C-type lectin SIGNR1 binds Schistosoma mansoni antigens in vitro, but SIGNR1-deficient mice have normal responses during schistosome infection.Dendritic cells activated by an anti-inflammatory agent induce CD4(+) T helper type 2 responses without impairing CD8(+) memory and effector cytotoxic T-lymphocyte responses.Temporal changes in macrophage phenotype after peripheral nerve injury.
P2860
Q26849454-94894CB9-5136-4C9A-9770-A126C2F6457EQ27345437-213C8474-3069-41F9-A803-1FFD8360DA30Q28274980-25ACF851-AB01-4B95-8DA0-70F4E654F1EFQ28547758-5B90B8D3-6EB1-469C-BEB7-46716AF92C14Q33587299-335A4AE4-B261-462F-BB48-C95258F373FBQ33675810-7388CF98-26E6-4B89-9D43-EBAA9824C809Q33836598-BD76104F-91BB-463A-B524-86F19373B563Q34776805-46B7883A-F423-4744-9CAE-DE6904160802Q35329145-8352F82B-FE8B-45FF-8E90-13AEBF1E7A45Q35784305-AE516774-F572-4A10-BCEA-B2D98D5CA46EQ35826651-83599383-DB38-4594-A3E8-D09188D323C2Q35996950-9A34D6C7-30E8-4202-B086-3DF498B77F40Q36385717-B48C291D-9A70-480B-8994-C6FC14F508C8Q36647259-91B420A7-2C3A-497A-8DE1-1AEF356B63D1Q36980266-19D3B6DD-477D-4BC6-B0A2-E2ACF7740656Q37572598-ECECD1BF-FCE4-4376-AE55-2FCE7916831FQ37651018-5E410DBB-38C5-4B60-BEE4-17DD1C99C12BQ37682953-7D3B608B-490E-4369-A71E-785C518E590DQ37693527-F7D9D052-B6D5-41CE-B318-03AE6CB4BCD6Q37695081-8ED7B0E1-12AB-4E3F-9F15-01E464DC0D5DQ37713387-E9D5EBA0-9AA0-4947-AE6B-F72BF0A8EC22Q38005601-A7A6DE66-86F0-4347-BF9F-FEAB70B470E3Q38271582-5919755A-B604-4BE5-BAF3-788EC06D5DEAQ38829051-B1C84056-D7F1-4E56-BEC3-51A5C9EAF8F5Q41480089-C578CAA3-D4F1-4861-8862-47F58959A01BQ41915030-00B6B647-1795-454E-A38C-233C7850A0B3Q48533957-79C9B44A-F6C7-471F-908B-72BFC8EA5FF2Q55429076-DB99D799-CEEF-42BC-8D61-6637E285CF75
P2860
The immunomodulatory glycan LNFPIII initiates alternative activation of murine macrophages in vivo.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
The immunomodulatory glycan LN ...... of murine macrophages in vivo.
@en
type
label
The immunomodulatory glycan LN ...... of murine macrophages in vivo.
@en
prefLabel
The immunomodulatory glycan LN ...... of murine macrophages in vivo.
@en
P2093
P2860
P1433
P1476
The immunomodulatory glycan LN ...... of murine macrophages in vivo.
@en
P2093
Akram A Da'dara
Donald A Harn
Mirjam Walker
Olga Atochina
P2860
P304
P356
10.1111/J.1365-2567.2008.02826.X
P577
2008-03-28T00:00:00Z